Wells Fargo Keeps Buy Rating on UNH.US with Target Price at $526

Wells Fargo's Stephen Baxter has maintained his buy rating for UnitedHealth (UNH.US), keeping the target price at $526. Baxter, who has a success rate of 50.4% and an average return of 4.1% over the past year, believes in the company's growth potential.

The analyst's recommendation is based on TipRanks data, which provides analysis from financial experts. According to TipRanks, a successful rating is one where their virtual portfolio earns a positive return from the stock.